FAIR VALUE MEASUREMENTS (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| FAIR VALUE MEASUREMENTS |
|
| Schedule valuation of the Company's financial instruments by fair value hierarchy levels |
The following table summarizes the valuation of the Company’s financial instruments by the above fair value hierarchy levels as of March 31, 2026 and December 31, 2025 (in thousands): | | | | | | | | | | | | | | | March 31, 2026 | Description | | Level 1 | | Level 2 | | Level 3 | | Total | Assets: | | | | | | | | | | | | | Available-for-sale securities | | $ | 49,280 | | $ | 4,690 | | $ | — | | $ | 53,970 | Marketable equity securities | | | 11,660 | | | — | | | — | | | 11,660 | Interest rate swap | | | — | | | 6,121 | | | — | | | 6,121 | Liabilities: | | | | | | | | | | | | | Contingent consideration | | | — | | | — | | | 2,835 | | | 2,835 | Cash-settled performance stock unit liability | | | — | | | — | | | 50,000 | | | 50,000 | Interest rate swap | | | — | | | 191 | | | — | | | 191 |
| | | | | | | | | | | | | | | December 31, 2025 | Description | | Level 1 | | Level 2 | | Level 3 | | Total | Assets: | | | | | | | | | | | | | Available-for-sale securities | | $ | 46,547 | | $ | 4,903 | | $ | — | | $ | 51,450 | Marketable equity securities | | | 14,213 | | | — | | | — | | | 14,213 | Interest rate swap | | | — | | | 918 | | | — | | | 918 | Liabilities: | | | | | | | | | | | | | Contingent consideration | | | — | | | — | | | 2,835 | | | 2,835 | Cash-settled performance stock unit liability | | | — | | | — | | | 50,000 | | | 50,000 | Interest rate swap | | | — | | | 2,963 | | | — | | | 2,963 |
|
| Schedule of insurance collateral |
Insurance collateral consisted of the following as of March 31, 2026 and December 31, 2025 (in thousands): | | | | | | | March 31, 2026 | | December 31, 2025 | Available-for-sale securities: | | | | | | U.S. Treasuries | $ | 9,860 | | $ | 2,778 | Corporate and municipal bonds | | 39,420 | | | 43,769 | Preferred or fixed rate cap securities | | 4,690 | | | 4,903 | Total available-for-sale securities | | 53,970 | | | 51,450 | Marketable equity securities | | 11,660 | | | 14,213 | Cash deposits and other | | 8,766 | | | 12,945 | Insurance Collateral | $ | 74,396 | | $ | 78,608 |
|
| Schedule of amortized cost basis and aggregate fair value of the Company's marketable securities |
Amortized cost basis and aggregate fair value of the Company’s marketable securities as of March 31, 2026 and December 31, 2025 were as follows (in thousands): | | | | | | | | | | | | | March 31, 2026 | | Cost Basis | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | Description: | | | | | | | | | | | | U.S. Treasuries | $ | 9,860 | | $ | — | | $ | — | | $ | 9,860 | Corporate and municipal bonds | | 39,195 | | | 674 | | | (449) | | | 39,420 | Preferred or fixed rate cap securities | | 5,620 | | | — | | | (930) | | | 4,690 | Total available-for-sale securities | | 54,675 | | | 674 | | | (1,379) | | | 53,970 | Marketable equity securities | | 10,372 | | | 1,817 | | | (529) | | | 11,660 | Total securities | $ | 65,047 | | $ | 2,491 | | $ | (1,908) | | $ | 65,630 |
| | | | | | | | | | | | | December 31, 2025 | | Cost Basis | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | Description: | | | | | | | | | | | | U.S. Treasuries | $ | 2,778 | | $ | — | | $ | — | | $ | 2,778 | Corporate and municipal bonds | | 43,234 | | | 920 | | | (385) | | $ | 43,769 | Preferred or fixed rate cap securities | | 5,619 | | | — | | | (716) | | | 4,903 | Total available-for-sale securities | | 51,631 | | | 920 | | | (1,101) | | | 51,450 | Marketable equity securities | | 11,698 | | | 2,855 | | | (340) | | | 14,213 | Total securities | $ | 63,329 | | $ | 3,775 | | $ | (1,441) | | $ | 65,663 |
|